Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL 32610-0267, USA.
Invest Ophthalmol Vis Sci. 2010 May;51(5):2697-704. doi: 10.1167/iovs.09-4137. Epub 2009 Dec 10.
Modulators of angiogenesis typically work in an orchestrated manner. The authors examined the interaction between insulinlike growth factor (IGF)-1, vascular endothelial growth factor (VEGF), and stromal derived factor (SDF)-1 in vivo and in vitro using angiogenesis models.
The angiogenic effect of SDF-1, alone or in combination with IGF-1 and VEGF, was assessed in human lung microvascular endothelial cells using capillary tube formation and thymidine incorporation. Immunohistochemical analysis for CD31, SDF-1, and CXCR4 was performed on mouse eyes 2 weeks after the initiation of laser rupture of Bruch's membrane, a choroidal neovascularization (CNV) model. CXCR4 antagonist and CXCR4 blocking antibody were tested on inhibition of CNV lesion size in this model. Real-time PCR was used to determine mRNA levels for SDF-1, VEGF, IGF-1, and their cognate receptors in the retinal pigment epithelium/choroid complex of mice that underwent this CNV model.
IGF-1 and VEGF demonstrated an additive effect on SDF-1-induced in vitro angiogenesis. CXCR4 immunoreactivity was present in both normal and laser-injured mice at the laser burn site and at the ganglion cell layer, the anterior portion of the inner nuclear layer, photoreceptors, and choroidal stroma. SDF-1 was observed in identical locations but was not seen in photoreceptors. mRNA levels for SDF-1, VEGF, and IGF-1 and their receptors were increased after laser injury. CXCR4-neutralizing antibody reduced neovascularization when injected subretinally but not intraperitoneally or intravitreally.
The potent proangiogenic factors IGF-1 and VEGF both stimulate SDF-1-induced angiogenesis. Local inhibition of CXCR4 is required for an antiangiogenic effect in CNV lesions.
血管生成调节剂通常以协调的方式发挥作用。作者使用血管生成模型在体内和体外研究了胰岛素样生长因子(IGF)-1、血管内皮生长因子(VEGF)和基质衍生因子(SDF)-1之间的相互作用。
使用毛细血管管形成和胸苷掺入法评估 SDF-1、单独或与 IGF-1 和 VEGF 联合对人肺微血管内皮细胞的血管生成作用。在脉络膜新生血管(CNV)模型中,在启动布鲁赫膜激光破裂后 2 周对小鼠眼睛进行 CD31、SDF-1 和 CXCR4 的免疫组织化学分析。在该模型中测试 CXCR4 拮抗剂和 CXCR4 阻断抗体对抑制 CNV 病变大小的作用。使用实时 PCR 确定接受此 CNV 模型的小鼠视网膜色素上皮/脉络膜复合物中 SDF-1、VEGF、IGF-1 及其同源受体的 mRNA 水平。
IGF-1 和 VEGF 对 SDF-1 诱导的体外血管生成表现出相加作用。CXCR4 免疫反应性存在于正常和激光损伤的小鼠的激光灼伤部位以及节细胞层、内核层前部、光感受器和脉络膜基质中。在相同的位置观察到 SDF-1,但在光感受器中未观察到。SDF-1、VEGF 和 IGF-1 及其受体的 mRNA 水平在激光损伤后增加。CXCR4 中和抗体在玻璃体内或腹膜内注射时不能减少新生血管化,但在玻璃体内注射时可以减少。
强大的促血管生成因子 IGF-1 和 VEGF 均可刺激 SDF-1 诱导的血管生成。局部抑制 CXCR4 是 CNV 病变抗血管生成作用所必需的。